{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:52:00Z","timestamp":1783389120253,"version":"3.54.6"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008723","name":"Finnish Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004012","name":"Jane and Aatos Erkko Fundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003125","name":"Finnish Cultural Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.tranon.2024.101935","type":"journal-article","created":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T10:09:14Z","timestamp":1711188554000},"page":"101935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Assessment of targeted therapy opportunities in sinonasal cancers using patient-derived functional tumor models"],"prefix":"10.1016","volume":"44","author":[{"given":"Noora","family":"Lehtinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Suhonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiesha","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2655-7021","authenticated-orcid":false,"given":"Eetu","family":"V\u00e4lim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3024-6282","authenticated-orcid":false,"given":"Mervi","family":"Toriseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5385-7065","authenticated-orcid":false,"given":"Johannes","family":"Routila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perttu","family":"Halme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Rahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Irjala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilmo","family":"Leivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Kallajoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Nees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3503-4094","authenticated-orcid":false,"given":"Teijo","family":"Kuopio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6672-6662","authenticated-orcid":false,"given":"Sami","family":"Ventel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4999-5585","authenticated-orcid":false,"given":"Juha K.","family":"Rantala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2024.101935_bib0001","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/hed.21830","article-title":"Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data","volume":"34","author":"Turner","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.tranon.2024.101935_bib0002","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1002\/cncr.28108","article-title":"Paranasal sinus squamous cell carcinoma incidence and survival based on surveillance, epidemiology, and end results data, 1973 to 2009","volume":"119","author":"Ansa","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.tranon.2024.101935_bib0003","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.canep.2013.09.014","article-title":"International comparisons of the incidence and mortality of sinonasal cancer","volume":"37","author":"Youlden","year":"2013","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.tranon.2024.101935_bib0004","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/lary.24264","article-title":"Epidemiology of sinonasal squamous cell carcinoma: a comprehensive analysis of 4994 patients","volume":"124","author":"Sanghvi","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.tranon.2024.101935_bib0005","series-title":"Centre International De Recherche Sur Le cancer, Eds. WHO Classification of Head and Neck Tumours","article-title":"Lyon: international agency for research on cancer","year":"2017"},{"key":"10.1016\/j.tranon.2024.101935_bib0006","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0002-9610(80)90209-3","article-title":"Combined modality therapy for advanced head and neck cancer","volume":"140","author":"Weaver","year":"1980","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.tranon.2024.101935_bib0007","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12901-018-0061-4","article-title":"Survival in sinonasal and middle ear malignancies: a population-based study using the SEER 1973\u20132015 database","volume":"18","author":"Gore","year":"2018","journal-title":"BMC Ear Nose Throat Disord."},{"key":"10.1016\/j.tranon.2024.101935_bib0008","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.oraloncology.2012.02.018","article-title":"KRAS and BRAF mutations in sinonasal cancer","volume":"48","author":"L\u00f3pez","year":"2012","journal-title":"Oral Oncol."},{"key":"10.1016\/j.tranon.2024.101935_bib0009","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12253-013-9730-1","article-title":"Low prevalence of K-RAS, EGF-R and BRAF mutations in sinonasal adenocarcinomas. Implications for anti-EGFR treatments","volume":"20","author":"Franchi","year":"2014","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.tranon.2024.101935_bib0010","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/PAS.0000000000001420","article-title":"IDH2 Mutation Analysis in Undifferentiated and Poorly Differentiated Sinonasal Carcinomas for Diagnosis and Clinical Management","volume":"44","author":"Riobello","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.tranon.2024.101935_bib0011","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.otohns.2008.10.038","article-title":"Microsatellite instability analysis of sinonasal carcinomas","volume":"140","author":"Mart\u00ednez","year":"2009","journal-title":"Otolaryngology\u2013Head Neck Surg."},{"key":"10.1016\/j.tranon.2024.101935_bib0012","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/hed.25067","article-title":"Programmed death ligand-1 expression as immunotherapeutic target in sinonasal cancer","volume":"40","author":"Riobello","year":"2018","journal-title":"Head Neck"},{"key":"10.1016\/j.tranon.2024.101935_bib0013","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.2147\/CMAR.S201568","article-title":"Clinical relevance and significance of programmed death-ligand 1 expression, tumor-infiltrating lymphocytes, and p16 status in sinonasal squamous cell carcinoma","volume":"11","author":"Quan","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.tranon.2024.101935_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.735820","article-title":"Ex vivo drug screening informed targeted therapy for metastatic parotid squamous cell carcinoma","volume":"11","author":"Nyk\u00e4nen","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2024.101935_bib0015","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.neo.2020.06.007","article-title":"Ex vivo assessment of targeted therapies in a rare metastatic epithelial\u2013myoepithelial carcinoma","volume":"22","author":"M\u00e4kel\u00e4","year":"2020","journal-title":"Neoplasia"},{"key":"10.1016\/j.tranon.2024.101935_bib0016","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/s12885-020-07092-w","article-title":"Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma","volume":"20","author":"M\u00e4kel\u00e4","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tranon.2024.101935_bib0017","unstructured":"INVIEW Oncoprofiling (591 genes) (former INVIEW Oncopanel All-in-one) [Internet]. [cited 27 January 2023]. Available at: https:\/\/eurofinsgenomics.eu\/en\/next-generation-sequencing\/applications\/oncology-solutions\/inview-oncoprofiling\/."},{"key":"10.1016\/j.tranon.2024.101935_bib0018","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1007\/s00405-021-06650-7","article-title":"Evaluation of prognostic biomarkers in a population-validated Finnish HNSCC patient cohort","volume":"278","author":"Routila","year":"2021","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.tranon.2024.101935_bib0019","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nmeth.3853","article-title":"Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs","volume":"13","author":"Hafner","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tranon.2024.101935_bib0020","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the cancer cell line encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2024.101935_bib0021","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/jcp.2004.016964","article-title":"Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma","volume":"57","author":"Kennedy","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.tranon.2024.101935_bib0022","first-page":"63","article-title":"CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract","volume":"445","author":"Franchi","year":"2004","journal-title":"Virchows Arch."},{"key":"10.1016\/j.tranon.2024.101935_bib0023","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/01.pas.0000126856.09058.71","article-title":"Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2","volume":"28","author":"Cathro","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.tranon.2024.101935_bib0024","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/jcp.2004.018051","article-title":"Expression of mismatch repair proteins, beta catenin, and E cadherin in intestinal-type sinonasal adenocarcinoma","volume":"57","author":"Perez-Ordonez","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.tranon.2024.101935_bib0025","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.humpath.2013.03.019","article-title":"Epidermal growth factor receptor expression and KRAS and BRAF mutations: study of 39 sinonasal intestinal-type adenocarcinomas","volume":"44","author":"Projetti","year":"2013","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.tranon.2024.101935_bib0026","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A landscape of pharmacogenomic interactions in cancer","volume":"166","author":"Iorio","year":"2016","journal-title":"Cell."},{"key":"10.1016\/j.tranon.2024.101935_bib0027","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/s41598-020-80242-z","article-title":"Next-generation sequencing for identification of actionable gene mutations in intestinal-type sinonasal adenocarcinoma","volume":"11","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2024.101935_bib0028","first-page":"199","article-title":"K-ras-2 and p53 genotyping of intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses","volume":"9","author":"Wu","year":"1996","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.tranon.2024.101935_bib0029","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ijc.25064","article-title":"Mutations in TP53 tumor suppressor gene in wood dust-related sinonasal cancer","volume":"127","author":"Holmila","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tranon.2024.101935_bib0030","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.humpath.2012.01.016","article-title":"Wood dust-related mutational profile of TP53 in intestinal-type sinonasal adenocarcinoma","volume":"43","author":"P\u00e9rez-Escuredo","year":"2012","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.tranon.2024.101935_bib0031","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00000478-200303000-00003","article-title":"CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin. An immunohistochemical survey of 476 primary and metastatic carcinomas","volume":"27","author":"Werling","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.tranon.2024.101935_bib0032","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.tranon.2024.101935_bib0033","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2024.101935_bib0034","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1530\/ERC-19-0420","article-title":"The epigenetic and transcriptional landscape of neuroendocrine prostate cancer","volume":"27","author":"Davies","year":"2020","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.tranon.2024.101935_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2380124","article-title":"ProgNOSTIC VALUe of EZH2 in non-small-cell lung cancers: a meta-analysis and bioinformatics analysis","volume":"2020","author":"Fan","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.tranon.2024.101935_bib0036","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccell.2019.06.005","article-title":"Pan-cancer convergence to a small-cell neuroendocrine phenotype that shares susceptibilities with hematological malignancies","volume":"36","author":"Balanis","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tranon.2024.101935_bib0037","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0194599812440932","article-title":"Meta-analysis of treatment outcomes for sinonasal undifferentiated carcinoma","volume":"147","author":"Reiersen","year":"2012","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.tranon.2024.101935_bib0038","first-page":"45","article-title":"Sinonasal undifferentiated carcinoma (SNUC): morphoproteomic-guided treatment paradigm with clinical efficacy","volume":"43","author":"Ansari","year":"2013","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.tranon.2024.101935_bib0039","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1097\/00000478-200212000-00007","article-title":"Sinonasal undifferentiated carcinoma, nasopharyngeal-type undifferentiated carcinoma, and keratinizing and nonkeratinizing squamous cell carcinoma express different cytokeratin patterns","volume":"26","author":"Franchi","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.tranon.2024.101935_bib0040","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/hed.21061","article-title":"Receptor tyrosine kinases in sinonasal undifferentiated carcinomas\u2014Evaluation for EGFR, c-KIT, and HER2\/neu expression","volume":"31","author":"Chernock","year":"2009","journal-title":"Head Neck"},{"key":"10.1016\/j.tranon.2024.101935_bib0041","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/path.4915","article-title":"Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas","volume":"242","author":"Dogan","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.tranon.2024.101935_bib0042","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/PAS.0000000000000797","article-title":"SMARCB1 (INI-1)-deficient sinonasal carcinoma: a series of 39 cases expanding the morphological and clinicopathological spectrum of a recently described entity","volume":"41","author":"Agaimy","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.tranon.2024.101935_bib0043","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1097\/PAS.0000000000000236","article-title":"SMARCB1(INI1)-deficient sinonasal basaloid carcinoma","volume":"38","author":"Agaimy","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.tranon.2024.101935_bib0044","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/PAS.0000000000000285","article-title":"SMARCB1 (INI-1) deficient carcinomas of the sinonasal tract","volume":"38","author":"Bishop","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.tranon.2024.101935_bib0045","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.3390\/ijms14035170","article-title":"EGFR Expression and KRAS and BRAF Mutational Status in Intestinal-Type Sinonasal Adenocarcinoma","volume":"14","author":"Szablewski","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2024.101935_bib0046","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hed.23795","article-title":"Study of MET protein levels and MET gene copy number in 72 sinonasal intestinal-type adenocarcinomas","volume":"37","author":"Projetti","year":"2015","journal-title":"Head Neck"},{"key":"10.1016\/j.tranon.2024.101935_bib0047","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s40265-020-01331-x","article-title":"Selumetinib: first approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.tranon.2024.101935_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00008","article-title":"CDX2: a prognostic marker in metastatic colorectal cancer defining a better braf mutated and a worse kras mutated subgroup","volume":"10","author":"Aaseb\u00f8","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2024.101935_bib0049","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","article-title":"Machine learning identifies stemness features associated with oncogenic dedifferentiation","volume":"173","author":"Malta","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2024.101935_bib0050","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.celrep.2018.08.062","article-title":"A human adult stem cell signature marks aggressive variants across epithelial cancers","volume":"24","author":"Smith","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.tranon.2024.101935_bib0051","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s12105-017-0783-4","article-title":"SMARCA4-deficient sinonasal carcinoma","volume":"11","author":"Agaimy","year":"2017","journal-title":"Head Neck Pathol."},{"key":"10.1016\/j.tranon.2024.101935_bib0052","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1073\/pnas.91.8.2905","article-title":"Five SWI\/SNF gene products are components of a large multisubunit complex required for transcriptional enhancement","volume":"91","author":"Peterson","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.tranon.2024.101935_bib0053","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-012414-040445","article-title":"SWI\/SNF chromatin remodeling and human malignancies","volume":"10","author":"Masliah-Planchon","year":"2015","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.tranon.2024.101935_bib0054","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1038\/s41388-021-01781-x","article-title":"Exploiting vulnerabilities of SWI\/SNF chromatin remodelling complexes for cancer therapy","volume":"40","author":"Wanior","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.tranon.2024.101935_bib0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mrfmmm.2008.07.010","article-title":"Roles of the EZH2 histone methyltransferase in cancer epigenetics","volume":"647","author":"Simon","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.tranon.2024.101935_bib0056","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ccr.2010.09.006","article-title":"Epigenetic antagonism between Polycomb and SWI\/SNF complexes during oncogenic transformation","volume":"18","author":"Wilson","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tranon.2024.101935_bib0057","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S1470-2045(20)30451-4","article-title":"Tazemetostat in advanced epithelioid sarcoma with loss of INI1\/SMARCB1: an international, open-label, phase 2 basket study","volume":"21","author":"Gounder","year":"2020","journal-title":"The Lancet Oncol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523324000627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523324000627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T07:01:37Z","timestamp":1713682897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523324000627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":57,"alternative-id":["S1936523324000627"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2024.101935","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of targeted therapy opportunities in sinonasal cancers using patient-derived functional tumor models","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2024.101935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. CCBYLICENSE","name":"copyright","label":"Copyright"}],"article-number":"101935"}}